Titan Pharmaceuticals
TTNP
#10775
Rank
โ‚น0.58 B
Marketcap
โ‚น439.86
Share price
-3.76%
Change (1 day)
29.59%
Change (1 year)

EPS for Titan Pharmaceuticals (TTNP)

EPS in 2025 (TTM): -โ‚น369.19

According to Titan Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -โ‚น418.87. In 2023 the company made an earnings per share (EPS) of -โ‚น707.03 an increase over its 2022 EPS that were of -โ‚น1,449.

EPS history for Titan Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น369.19
2023-โ‚น707.03-51.22%
2022-โ‚น1,449-15.61%
2021-โ‚น1,717-81.37%
2020-โ‚น9,217-77.52%
2019-โ‚น41,009-56.32%
2018-โ‚น93,889-59.51%
2017-โ‚น2,31,907-371.81%
2016โ‚น85,319-144.35%
2015-โ‚น1,92,358300%
2014-โ‚น48,090-121.54%
2013โ‚น2,23,273-151.38%
2012-โ‚น4,34,524-11.54%
2011-โ‚น4,91,201188.89%
2010-โ‚น1,70,031-10%
2009-โ‚น1,88,923
2007-โ‚น7,74,586-2.38%
2006-โ‚น7,93,478-39.13%
2005-โ‚น13,03,571-16.87%
2004-โ‚น15,68,064-22.43%
2003-โ‚น20,21,4804.9%
2002-โ‚น19,27,01961.9%
2001-โ‚น11,90,217-13.7%
2000-โ‚น13,79,14165.01%
1999-โ‚น8,35,806-35.87%
1998-โ‚น13,03,349-1824.71%
1997โ‚น75,569-102.4%
1996-โ‚น31,55,021

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น833.58-299.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น669.81-259.91%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
-โ‚น135.49-67.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
โ‚น87.78-120.96%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-โ‚น23.85-94.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น371.16-11.39%๐Ÿ‡บ๐Ÿ‡ธ USA